C Partners Holding’s Bristol-Myers Squibb BMY Stock Holding History

C Partners Holding’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,977	Closed	-$123K	–	51
2018 Q3	$123K	Sell	1,977 -2,244	-53%	-$133K	0.04%	117
2018 Q2	$234K	Buy	4,221 +662	+19%	+$35.8K	0.09%	108
2018 Q1	$225K	Sell	3,559 -697	-16%	-$44.8K	0.09%	81
2017 Q4	$261K	Buy	+4,256	New	+$266K	0.11%	189

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

C Partners Holding's BMY Position: Q4 2018 in Review

C Partners Holding sold out of Bristol-Myers Squibb (BMY) in Q4 2018, closing a stake of 1,977 shares — an estimated $123K sold.

C Partners Holding first reported a position in BMY in Q4 2017 and held it in 4 quarters. The position peaked at $261K in Q4 2017. 1,765 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

C Partners Holding reported no remaining Bristol-Myers Squibb position as of Q4 2018 after selling out during the quarter.
C Partners Holding sold 1,977 Bristol-Myers Squibb shares in Q4 2018, an estimated $123K.
C Partners Holding first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 4 quarters.
C Partners Holding's Bristol-Myers Squibb position peaked at $261K in Q4 2017.
1,765 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on C Partners Holding's 13F filing for Q4 2018, filed 7 Feb 2019.